Pfizer and BioNTech have announced topline Phase 3 clinical trial data showing a robust immune...
NEWS
Nutrien to Divest 50% Equity Stake in Profertil S.A. for US$600...
Nutrien Ltd. has announced an agreement to sell its 50 percent equity stake in Argentina-based...
Novartis to Acquire Tourmaline Bio, Expanding Cardiovascular...
Novartis has announced plans to acquire Tourmaline Bio, strengthening its cardiovascular pipeline...
Sanofi Gene Therapy Gains FDA Fast Track Designation for Wet Age...
Sanofi has announced that the US Food and Drug Administration (FDA) has granted Fast Track...

